Evoke Pharma Net Worth 2012-2025 | EVOK

Interactive chart of historical net worth (market cap) for Evoke Pharma (EVOK) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Evoke Pharma net worth as of May 19, 2025 is $0B.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.005B $0.010B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.298B 6.98
Dr Reddy's Laboratories (RDY) India $12.071B 21.91
BridgeBio Pharma (BBIO) United States $6.397B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.850B 15.02
Bausch Health Cos (BHC) Canada $1.681B 1.24
Amphastar Pharmaceuticals (AMPH) United States $1.178B 7.84
Taysha Gene Therapies (TSHA) United States $0.599B 0.00
Personalis (PSNL) United States $0.443B 0.00
Assembly Biosciences (ASMB) United States $0.105B 0.00
Sol-Gel Technologies (SLGL) Israel $0.021B 0.00
Teligent (TLGT) United States $0.000B 0.00